Niraparib-induced pure red cell aplasia.
Kadriye Bir YücelSeyma YıldızOsman SütçüoğluFatma Sena GüvercinPınar Uyar GöçünNuriye ÖzdemirOzan YazıcıAhmet ÖzetPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
In daily practice, it should be kept in mind that in the case of refractory anemia induced by niraparib, the underlying cause might be PRCA and can be improved with steroid administration.